Ridinilazole

N/A

Report date: 2023/01/02 21:18:52
NMEQIDP

Base Information

Drug NameRidinilazole
Drug Alias NameRidinilazol利地利唑利地尼唑RidinilazolumSMT-19969
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCell division inhibitorsDNA synthesis inhibitors
TargetsDNA
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[28] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSummit Pharmaceuticals International
China Registration ClassN/A

Develop Information

Active CompaniesSummit Therapeutics
Inactive CompaniesN/A
Active IndicationsClostridium Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia